Updated: Apr 2026
89%
Employees say this is a great place to work
Molecular Partners is a clinical-stage biotechnology company pioneering the design and development of DARPin (Designed Ankyrin Repeat Protein) therapeutics for oncological challenges that cannot be readily addressed by other drug classes. The spectrum covers next-generation immune cell binders to targeted radio-DARPin therapeutics.
(Zurich)
Certification March 2026
Certification March 2024
Certification December 2022
Certification March 2026
Certification March 2024
Certification December 2022
You are currently viewing placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information
